Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
探索纳武利尤单抗单药治疗既往接受过治疗的晚期胃癌和胃食管交界处癌患者获益的预测因素：ATTRACTION-2 研究的事后亚组分析
期刊:Gastric Cancer
影响因子:6
doi:10.1007/s10120-021-01230-4.
Yoon-Koo Kang,Satoshi Morita,Taroh Satoh,Min-Hee Ryu,Yee Chao,Ken Kato,Hyun Cheol Chung,Jen-Shi Chen,Kei Muro,Won Ki Kang,Kun-Huei Yeh,Takaki Yoshikawa,Sang Cheul Oh,Li-Yuan Bai,Takao Tamura,Keun-Wook Lee,Yasuo Hamamoto,Jong Gwang Kim,Keisho Chin,Do-Youn Oh,Keiko Minashi,Jae Yong Cho,Masahiro Tsuda,Hiroki Sameshima,Li-Tzong Chen,Narikazu Boku
